159 related articles for article (PubMed ID: 17241926)
1. Systematic review of controlled clinical trials on the use of ursodeoxycholic acid for the prevention of hepatic veno-occlusive disease in hematopoietic stem cell transplantation.
Tay J; Tinmouth A; Fergusson D; Huebsch L; Allan DS
Biol Blood Marrow Transplant; 2007 Feb; 13(2):206-17. PubMed ID: 17241926
[TBL] [Abstract][Full Text] [Related]
2. Interventions for prophylaxis of hepatic veno-occlusive disease in people undergoing haematopoietic stem cell transplantation.
Cheuk DK; Chiang AK; Ha SY; Chan GC
Cochrane Database Syst Rev; 2015 May; 2015(5):CD009311. PubMed ID: 26017019
[TBL] [Abstract][Full Text] [Related]
3. Optimal approach to prevent veno-occlusive disease following hematopoietic stem cell transplantation in children.
Hassan Z
Pediatr Transplant; 2010 Sep; 14(6):683-7. PubMed ID: 20353406
[No Abstract] [Full Text] [Related]
4. How can we reduce hepatic veno-occlusive disease-related deaths after allogeneic stem cell transplantation?
Johnson DB; Savani BN
Exp Hematol; 2012 Jul; 40(7):513-7. PubMed ID: 22542577
[TBL] [Abstract][Full Text] [Related]
5. Use of prophylactic anticoagulation and the risk of hepatic veno-occlusive disease in patients undergoing hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Imran H; Tleyjeh IM; Zirakzadeh A; Rodriguez V; Khan SP
Bone Marrow Transplant; 2006 Apr; 37(7):677-86. PubMed ID: 16489362
[TBL] [Abstract][Full Text] [Related]
6. Defibrotide for the prevention of hepatic veno-occlusive disease after hematopoietic stem cell transplantation: a systematic review.
Zhang L; Wang Y; Huang H
Clin Transplant; 2012; 26(4):511-9. PubMed ID: 22428954
[TBL] [Abstract][Full Text] [Related]
7. The Japanese multicenter open randomized trial of ursodeoxycholic acid prophylaxis for hepatic veno-occlusive disease after stem cell transplantation.
Ohashi K; Tanabe J; Watanabe R; Tanaka T; Sakamaki H; Maruta A; Okamoto S; Aotsuka N; Saito K; Nishimura M; Oh H; Matsuzaki M; Takahashi S; Yonekura S
Am J Hematol; 2000 May; 64(1):32-8. PubMed ID: 10815785
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and Safety of Recombinant Thrombomodulin for the Prophylaxis of Veno-Occlusive Complication in Allogeneiccit Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.
Kashyap R; Anwer F; Iqbal MA; Khalid F; Khan A; Ali MA; Anwar MY; Chaudhary A; Jaan A
Hematol Oncol Stem Cell Ther; 2023 Jan; 16(2):93-101. PubMed ID: 34655527
[TBL] [Abstract][Full Text] [Related]
9. Ursodiol prophylaxis against hepatic complications of allogeneic bone marrow transplantation. A randomized, double-blind, placebo-controlled trial.
Essell JH; Schroeder MT; Harman GS; Halvorson R; Lew V; Callander N; Snyder M; Lewis SK; Allerton JP; Thompson JM
Ann Intern Med; 1998 Jun; 128(12 Pt 1):975-81. PubMed ID: 9625683
[TBL] [Abstract][Full Text] [Related]
10. Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial.
Corbacioglu S; Cesaro S; Faraci M; Valteau-Couanet D; Gruhn B; Rovelli A; Boelens JJ; Hewitt A; Schrum J; Schulz AS; Müller I; Stein J; Wynn R; Greil J; Sykora KW; Matthes-Martin S; Führer M; O'Meara A; Toporski J; Sedlacek P; Schlegel PG; Ehlert K; Fasth A; Winiarski J; Arvidson J; Mauz-Körholz C; Ozsahin H; Schrauder A; Bader P; Massaro J; D'Agostino R; Hoyle M; Iacobelli M; Debatin KM; Peters C; Dini G
Lancet; 2012 Apr; 379(9823):1301-9. PubMed ID: 22364685
[TBL] [Abstract][Full Text] [Related]
11. Coexisting or underlying risk factors of hepatic veno-occlusive disease in pediatric hematopoietic stem cell transplant recipients receiving prophylaxis.
Gökce M; Kuskonmaz B; Cetin M; Uckan Cetinkaya D; Tuncer M
Exp Clin Transplant; 2013 Oct; 11(5):440-6. PubMed ID: 24128137
[TBL] [Abstract][Full Text] [Related]
12. BCSH/BSBMT guideline: diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation.
Dignan FL; Wynn RF; Hadzic N; Karani J; Quaglia A; Pagliuca A; Veys P; Potter MN; ;
Br J Haematol; 2013 Nov; 163(4):444-57. PubMed ID: 24102514
[TBL] [Abstract][Full Text] [Related]
13. The hemochromatosis C282Y allele: a risk factor for hepatic veno-occlusive disease after hematopoietic stem cell transplantation.
Kallianpur AR; Hall LD; Yadav M; Byrne DW; Speroff T; Dittus RS; Haines JL; Christman BW; Summar ML
Bone Marrow Transplant; 2005 Jun; 35(12):1155-64. PubMed ID: 15834437
[TBL] [Abstract][Full Text] [Related]
14. Low Incidence of hepatic sinusoidal obstruction syndrome/veno-occlusive disease in adults undergoing allogenic stem cell transplantation with prophylactic ursodiol and low-dose heparin.
Stutz L; Halter JP; Heim D; Passweg JR; Medinger M
Bone Marrow Transplant; 2022 Mar; 57(3):391-398. PubMed ID: 34980902
[TBL] [Abstract][Full Text] [Related]
15. [A clinical analysis of hepatic veno-occlusive disease after hematopoietic stem cell transplantation].
Qin CJ; Liu LJ; Zhang ZM; Luo L; Lai YR; Li QC
Zhonghua Nei Ke Za Zhi; 2018 Jul; 57(7):483-486. PubMed ID: 29996265
[No Abstract] [Full Text] [Related]
16. Defibrotide in the prevention and treatment of veno-occlusive disease in autologous and allogeneic stem cell transplantation in children.
Qureshi A; Marshall L; Lancaster D
Pediatr Blood Cancer; 2008 Apr; 50(4):831-2. PubMed ID: 18286502
[TBL] [Abstract][Full Text] [Related]
17. Low incidence of hepatic veno-occlusive disease in pediatric patients undergoing hematopoietic stem cell transplantation attributed to a combination of intravenous heparin, oral glutamine, and ursodiol at a single transplant institution.
Lakshminarayanan S; Sahdev I; Goyal M; Vlachos A; Atlas M; Lipton JM
Pediatr Transplant; 2010 Aug; 14(5):618-21. PubMed ID: 20051023
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of immunoglobulin prophylaxis in reducing clinical complications of hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Ahn H; Tay J; Shea B; Hutton B; Shorr R; Knoll GA; Cameron DW; Cowan J
Transfusion; 2018 Oct; 58(10):2437-2452. PubMed ID: 29770447
[TBL] [Abstract][Full Text] [Related]
19. [Preventive effect of integrated Chinese and Western medicine on hepatic veno-occlusive disease after hematopoietic stem cell transplantation].
Liu J; Zhang X; Chen XH
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Oct; 30(10):1049-51. PubMed ID: 21066888
[TBL] [Abstract][Full Text] [Related]
20. Defibrotide for children and adults with hepatic veno-occlusive disease post hematopoietic cell transplantation.
Corbacioglu S; Richardson PG
Expert Rev Gastroenterol Hepatol; 2017 Oct; 11(10):885-898. PubMed ID: 28825848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
